Your browser doesn't support javascript.
loading
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B).
Atkins, Michael B; Jegede, Opeyemi A; Haas, Naomi B; McDermott, David F; Bilen, Mehmet A; Stein, Mark; Sosman, Jeffrey A; Alter, Robert; Plimack, Elizabeth R; Ornstein, Moshe C; Hurwitz, Michael; Peace, David J; Signoretti, Sabina; Denize, Thomas; Cimadamore, Alessia; Wu, Catherine J; Braun, David; Einstein, David; Catalano, Paul J; Hammers, Hans.
Afiliação
  • Atkins MB; Oncology, Georgetown University, Washington, District of Columbia, USA mba41@Georgetown.edu.
  • Jegede OA; Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Haas NB; Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.
  • McDermott DF; Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Bilen MA; Department of Hematology and Medical Oncology, Emory University Winship Cancer Institute, Atlanta, Georgia, USA.
  • Stein M; Oncology, Columbia University, New York, New York, USA.
  • Sosman JA; Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Alter R; Hematology Oncology, John Theurer Cancer Center, Hackensack, New Jersey, USA.
  • Plimack ER; Hematology Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Ornstein MC; Hematology Oncology, Taussig Cancer Institute, Cleveland, Ohio, USA.
  • Hurwitz M; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Peace DJ; Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Signoretti S; Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Denize T; Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Cimadamore A; Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Wu CJ; Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Braun D; Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA.
  • Einstein D; Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Catalano PJ; Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Hammers H; Medicine, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
J Immunother Cancer ; 11(3)2023 03.
Article em En | MEDLINE | ID: mdl-36948504
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Carcinoma de Células Renais Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles / Carcinoma de Células Renais Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos